User login
NEW YORK – Selecting patients according to genotype and repurposing existing drugs for use in combination with drugs that enhance psychosocial interventions are among the new therapeutic opportunities in treating schizophrenia, Dr. Donald C. Goff said in an interview during the annual meeting of the American Psychiatric Association.
In this video, Dr. Goff of the Nathan Kline Institute for Psychiatric Research at New York University also discusses how combining drugs with psychosocial interventions can lead to areas of growth.
NEW YORK – Selecting patients according to genotype and repurposing existing drugs for use in combination with drugs that enhance psychosocial interventions are among the new therapeutic opportunities in treating schizophrenia, Dr. Donald C. Goff said in an interview during the annual meeting of the American Psychiatric Association.
In this video, Dr. Goff of the Nathan Kline Institute for Psychiatric Research at New York University also discusses how combining drugs with psychosocial interventions can lead to areas of growth.
NEW YORK – Selecting patients according to genotype and repurposing existing drugs for use in combination with drugs that enhance psychosocial interventions are among the new therapeutic opportunities in treating schizophrenia, Dr. Donald C. Goff said in an interview during the annual meeting of the American Psychiatric Association.
In this video, Dr. Goff of the Nathan Kline Institute for Psychiatric Research at New York University also discusses how combining drugs with psychosocial interventions can lead to areas of growth.
FROM THE APA ANNUAL MEETING
